Product Pipeline
AVONEX® (Interferon beta-1a)
	MS-Open Label
	MS-Monosymptomatic (CHAMPS)
	MS-Secondary Progressive
	MS-Combination Trials
AMEVIVE® (alefacept)
	Psoriasis
ANTEGREN® (natalizumab)
	MS
	Crohn's disease
ADENTRI™ (adenosine A1 antagonist)
	Congestive heart failure
Lymphotoxin Beta Receptor
	Autoimmune diseases
Interferon Beta Gene Delivery
	Cancer indications
VLA-1 mAb
	Inflammation and Fibrosis
VLA-4 Inhibitor
	Inflammation
LTBR mAb
	Solid tumors

LTBR mAb

Anti-lymphotoxin beta receptor (LTBR) monoclonal antibody. LTBR is a member of the TNF superfamily of cytokines. The activation of LTBR has been demonstrated to inhibit tumor growth in animal models. An agonist antibody against this target has been generated.

Terms and Conditions of Use // Copyright © BIOGEN. Designed by Foster Design Group, Inc., and created and maintained by embarc. // Note Regarding Forward Looking Statements // Privacy Policy